Hypertension is the leading cause of death among the different cardiovascular risk factors. Studies have found that differences in the prevalence of hypertension exist depending on gender, age, race, socio-demographic characteristics and geographical location. In this study, we aimed to determine the prevalence of hypertension according to gender and regional distribution during the last five years in Turkey. The diagnosis of essential hypertension in individuals was determined from across the country based on data from 2009-2013 obtained from Social Security Insurance. From the data of this study, the prevalence of hypertension was found to be significantly greater for both sexes in the Black Sea Region for all the years surveyed. The prevalence of hypertension in women was found to be higher than men in all geographic areas (p
___
1. Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK, He J. Global burden of hypertension: analysis of worldwide data. Lancet. 2005;365(9455):217-23.
2. Lenfant C. Reflections on hypertension control rates: a message from the director of the National Heart, Lung, and Blood Institute. Arch Intern Med. 2002;162(2):131-2.
3. Bramlage P, Böhm M, Volpe M, Khan BV, Paar WD, Tebbe U, Thoenes M. A global perspective on blood pressure treatment and control in a referred cohort of hypertensive patients. J Clin Hypertens (Greenwich). 2010;12(9):666-77.
4. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens. 2004;22(1):11-9.
5. Levine DA, Lewis CE, Williams OD, Safford MM, Liu K, Calhoun DA, Kim Y, Jacobs DR Jr, Kiefe CI. Geographic and demographic variability in 20-year hypertension incidence: the CARDIA study. Hypertension. 2011;57(1):39-47.
6. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodríguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F. Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA. 2003;289(18):2363-9.
7. Stein KV, Rieder A, Dorner TE. East-West gradient in cardio-vascular mortality in Austria: how much can we explain by following the pattern of risk factors? Int J Health Geogr. 2011;10:59-70.
8. Meisinger C, Heier M, Völzke H, Löwel H, Mitusch R, Hense HW, Lüdemann J. Regional disparities of hypertension prevalence and management within Germany. J Hypertens. 2006;24(2):293-9.
9. Reynolds K, Gu D, Muntner P, Wu X, Chen J, Huang G, Duan X, Whelton PK, He J; InterASIA Collaborative Group. Geographic variations in the prevalence, awareness, treatment and control of hypertension in China. J Hypertens. 2003;21(7):1273-81.
10. Wagner A, Sadoun A, Dallongeville J, Ferrières J, Amouyel P, Ruidavets JB, Arveiler D. High blood pressure prevalence and control in a middle-aged French population and their associated factors: the MONA LISA study. J Hypertens. 2011;29(1):43-50.
11. Erceg M, Kern J, Babic-Erceg A, Iviceviv-Uhernik A, Vuletic S. Regional differences in the prevalence of arterial hypertension in Croatia. Coll Antropol. 2009;33(1):19-23.
12. National High Blood Pressure Education Program. NIH publication no 93–2669. Bethesda, MD: U.S. Department of Health and Human Services, National Heart, Lung, and Blood Institute; 1993. National High Blood Pressure Education Program working group on primary prevention of hypertension. 1993;153(2):186-208
13. Altun B, Arici M, Nergizoğlu G, Derici U, Karatan O, Turgan C, Sindel S, Erbay B, Hasanoğlu E, Cağlar S; Turkish Society of Hypertension and Renal Diseases. Prevalence, awareness, treatment and control of hypertension in Turkey (the PatenT study) in 2003. J Hypertens. 2005;23(10):1817-23.
14. Süleymanlar G, Utaş C, Arinsoy T, Ateş K, Altun B, Altiparmak MR, Ecder T, Yilmaz ME, Çamsari T, Başçi A, Odabas AR, Serdengeçti K. A population-based survey of Chronic REnal Disease In Turkey--the CREDIT study. Nephrol Dial Transplant. 2011;26(6):1862-71.